The search frequency for Shinil Pharmaceutical, recently known as a manufacturer of finished pharmaceutical products, has surged.

As of 2:30 PM on the 30th, Shinil Pharmaceutical's stock price is 14,050 KRW, down 6.95% from the previous day, with a trading volume of 1,433,766 shares, which is about 26.16% of the 5-day average trading volume. Foreign investors are tentatively reported to have sold a net 2,000 shares today.

On June 29, Shinil Pharmaceutical became a market issue with the news, "114-year-old Ethiopian male COVID-19 patient treated with Dexamethasone..."



[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing